Loading grant details…
Atle 180 - internationalization & competence improvement
| Funder | Vinnova |
|---|---|
| Recipient Organization | Draghjälp Ab |
| Country | Sweden |
| Start Date | Aug 01, 2023 |
| End Date | Apr 01, 2024 |
| Duration | 244 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2023-01606_Vinnova |
Grant Description
Purpose and goal: - Mapped regulatory pathway into non-EU countries: UK, Switzerland, USA and Canada. - Created stronger market understanding for UK&I Expected results and effects:
- Mapping of needs and regulatory eligibility requirements in Great Britain has resulted in establishment of Njord Medtech Ltd in 2024
- Mapping of regulatory eligibility requirements in Switzerland has resulted in establishment in 2024 via CH-Rep MedEnvoy - Mapping of regulatory eligibility requirements in the USA and Canada completed, no decision taken yet. Approach and implementation: ** Denna text är maskinöversatt ** Commercial market analysis in the UK was carried out by an on-site consultant who has worked in the NHS for +30-years.
Regulatory mapping of Atle 180 introduction in England, Switzerland, USA, Canada was carried out by experienced QA&RA consultant based in Sweden
All Grantees
Draghjälp Ab
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
